Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions - PubMed (original) (raw)
Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions
Karine Passebosc-Faure et al. Clin Cancer Res. 2005.
Abstract
Purpose: Our main goal was to evaluate a panel of molecular markers for the detection of cancer cells in serous effusions and to determine their value as an adjunctive reverse transcription-PCR (RT-PCR) test to cytologic examination.
Experimental design: One hundred fourteen serous effusions from 71 patients with tumors and 43 patients with benign diseases were subjected to RT-PCR for expression of carcinoembryonic antigen (CEA), epithelial cell adhesion molecule (Ep-CAM), E-cadherin, mammaglobin, mucin 1 (MUC1) isoforms MUC1/REP, MUC1/Y, and MUC1/Z, calretinin, and Wilms' tumor 1 susceptibility gene.
Results: CEA, Ep-CAM, E-cadherin, and mammaglobin were specifically expressed in malignant effusions. The sensitivity of RT-PCR in cytologically negative malignant effusions was 63.1% combining CEA and Ep-CAM (with 100% specificity) and reached 78.9% adding MUC1/Y or MUC1/Z (with 93% specificity). In the whole population of effusions, the combination of cytology with RT-PCR of CEA and Ep-CAM yielded a 90.1% sensitivity, a specificity and a positive predictive value of 100%, and a 86% negative predictive value for malignancy. Adding MUC1/Y or MUC1/Z to the panel, the sensitivity was 94.5% with 93% specificity, 95.7% PPV, and 90.9% negative predictive value. Moreover, CEA and mammaglobin were specifically expressed in epithelial malignancies, and mammaglobin was mainly expressed in effusions from breast carcinoma (97.3% of specificity).
Conclusions: A combination of cytology and RT-PCR analysis of CEA and Ep-CAM significantly improved the detection sensitivity of tumor cells in serous effusions. RT-PCR analysis of CEA, Ep-CAM, and mammaglobin in serous effusions could be a beneficial adjunct to cytology for the diagnosis of malignancy.
Similar articles
- Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
Sun W, Li J, Jiang HG, Ge LP, Wang Y. Sun W, et al. QJM. 2014 Dec;107(12):1001-7. doi: 10.1093/qjmed/hcu130. Epub 2014 Jun 16. QJM. 2014. PMID: 24939190 - Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells.
Raynor M, Stephenson SA, Walsh DC, Pittman KB, Dobrovic A. Raynor M, et al. BMC Cancer. 2002 May 24;2:14. doi: 10.1186/1471-2407-2-14. BMC Cancer. 2002. PMID: 12031094 Free PMC article. - Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Fiegl M, Haun M, Massoner A, Krugmann J, Müller-Holzner E, Hack R, Hilbe W, Marth C, Duba HC, Gastl G, Grünewald K. Fiegl M, et al. J Clin Oncol. 2004 Feb 1;22(3):474-83. doi: 10.1200/JCO.2004.06.063. J Clin Oncol. 2004. PMID: 14752070 - Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature.
Murugan P, Siddaraju N, Habeebullah S, Basu D. Murugan P, et al. Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):175-81. doi: 10.4103/0377-4929.48910. Indian J Pathol Microbiol. 2009. PMID: 19332905 Review. - Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
Tozzoli R, Basso SM, D'Aurizio F, Metus P, Lumachi F. Tozzoli R, et al. Clin Biochem. 2016 Nov;49(16-17):1227-1231. doi: 10.1016/j.clinbiochem.2016.08.006. Epub 2016 Aug 10. Clin Biochem. 2016. PMID: 27521620 Review.
Cited by
- Porphyromonas gingivalis upregulates calbindin 1 and thus promotes the proliferation of gingival epithelial cells.
Zhang Y, He Y, Ding Y, Liu C. Zhang Y, et al. Hua Xi Kou Qiang Yi Xue Za Zhi. 2022 Jan 25;40(1):93-99. doi: 10.7518/hxkq.2022.01.014. Hua Xi Kou Qiang Yi Xue Za Zhi. 2022. PMID: 38596999 Free PMC article. Chinese, English. - mRNA markers associated with malignant pleural effusion.
Hsu SC, Chang SY, Hwang YT, Terng HJ, Tsai CL, Shen CH, Huang SK, Chian CF. Hsu SC, et al. Sci Rep. 2023 Apr 24;13(1):6677. doi: 10.1038/s41598-023-32872-2. Sci Rep. 2023. PMID: 37095178 Free PMC article. - Molecular testing on serous effusion: An update.
Sahu S, Gupta P, Dey P. Sahu S, et al. Cytojournal. 2021 Dec 6;18:35. doi: 10.25259/Cytojournal_55_2020. eCollection 2021. Cytojournal. 2021. PMID: 35126613 Free PMC article. Review. - Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J, Ding J, Deng L, Xiang Y, Liu D, Zhang Y, Chen X, Yang Q. Zhong J, et al. Drug Des Devel Ther. 2021 Sep 21;15:3985-3996. doi: 10.2147/DDDT.S322854. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34584404 Free PMC article. - Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
Del Bano J, Chames P, Baty D, Kerfelec B. Del Bano J, et al. Antibodies (Basel). 2015 Dec 26;5(1):1. doi: 10.3390/antib5010001. Antibodies (Basel). 2015. PMID: 31557983 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous